Clinical Trial Update: An Inpatient Evaluation of Six-Day Subcutaneous Glucose Sensor Performance [NA]

View source ↗

Summary

Completed inpatient study evaluating six-day subcutaneous glucose sensor performance in diabetes patients; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Six-Day Subcutaneous Glucose Sensor

Snippet

Sponsor: Medtronic MiniMed, Inc. | Conditions: Diabetes | NA | Status: COMPLETED | Results posted: 2012-08-27